Propanc Biopharma, Inc. (PPCB) › Net IncomePropanc Biopharma, Inc. (PPCB) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$443.8K2010: -$842.5K2011: -$2.15M2012: -$11.43M2013: -$1.44M2014: -$829.6K2015: -$3.41M2016: -$9.41M2017: -$7.87M2018: -$7.04M2019: -$5.76M2020: -$4.74M2021: -$2.03M2022: -$2.66M2023: -$2.66M2024: -$1.82M2025: -$58.92M-$58.92M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$58.92M-3136.6%2024-$1.82M+31.6%2023-$2.66M-0.1%2022-$2.66M-31.2%2021-$2.03M+57.3%2020-$4.74M+17.7%2019-$5.76M+18.2%2018-$7.04M+10.5%2017-$7.87M+16.4%2016-$9.41M-175.7%2015-$3.41M-311.4%2014-$829.6K+42.5%2013-$1.44M+87.4%2012-$11.43M-431.3%2011-$2.15M-155.4%2010-$842.5K-89.8%2009-$443.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share